Tesla Leads Nasdaq 100 Gains While Moderna Falls Behind

In early trading on Tuesday, Tesla’s stock stood out on the Nasdaq 100 index, climbing by 3.5%. So far this year, Tesla has impressively risen by 79.3%.

On the flip side, Moderna struggled as the worst performer in the index, trading down 1.3%. Over the year, Moderna’s share price has meanwhile plummeted by about 60.7%.

Additional movements in the Nasdaq 100 include Biogen, which is trading down 1.2%, and Broadcom, with a rise of 1.6% on the day.

VIDEO: Nasdaq 100 Movers: MRNA, TSLA

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.